These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34812287)

  • 1. Adverse reactions following COVID-19 vaccination: An Ecuadorian experience.
    Vanegas E; Robles-Velasco K; Osorio MF; Farfán Bajaña MJ; Sarfraz Z; Sarfraz A; Fernández Cadena JC; Andrade Molina DM; Panchana Lascano M; Cherrez-Ojeda I
    Ann Med Surg (Lond); 2021 Dec; 72():103044. PubMed ID: 34812287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Skin reactions to the Pfizer-BioNTech vaccine for COVID-19. An Ecuadorian experience].
    Chérrez-Ojeda I; Robles-Velasco K; Osorio MF; Mejía-Leiva D; Chérrez A; Chérrez S; Bernstein JA; Sarfraz Z; Félix M
    Rev Alerg Mex; 2022 Jun; 69(1):61-64. PubMed ID: 36927752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore.
    Lim SM; Chan HC; Santosa A; Quek SC; Liu EHC; Somani J
    Ann Acad Med Singap; 2021 Sep; 50(9):703-711. PubMed ID: 34625758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review.
    Dighriri IM; Alhusayni KM; Mobarki AY; Aljerary IS; Alqurashi KA; Aljuaid FA; Alamri KA; Mutwalli AA; Maashi NA; Aljohani AM; Alqarni AM; Alfaqih AE; Moazam SM; Almutairi MN; Almutairi AN
    Cureus; 2022 Mar; 14(3):e23526. PubMed ID: 35494952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews.
    Abu-Halaweh S; Alqassieh R; Suleiman A; Al-Sabbagh MQ; AbuHalaweh M; AlKhader D; Abu-Nejem R; Nabulsi R; Al-Tamimi M; Alwreikat M; Alnouti M; Suleiman B; Yousef M; Jarbeh ME; Al-Shudifat AE; Alqassieh A; Bsisu I
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-vaccination Adverse Reactions After Receiving the Pfizer-BioNTech Coronavirus Disease 2019 Vaccines Among Healthcare Workers in Sapporo, Japan.
    Shimamura Y; Anbo Y; Furuta Y
    Cureus; 2022 Mar; 14(3):e23549. PubMed ID: 35494967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta's state hospital.
    Cuschieri S; Borg M; Agius S; Souness J; Brincat A; Grech V
    Int J Clin Pract; 2021 Oct; 75(10):e14605. PubMed ID: 34228863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience.
    Sauserienė J; Liseckienė I; Neverauskė V; Šepetauskienė E; Serapinas D; Mačinskas Š; Šitkauskienė B; Bajoriūnienė I; Vaičiūnienė R; Valius L
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334616
    [No Abstract]   [Full Text] [Related]  

  • 11. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
    Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe.
    Dziedzic A; Riad A; Attia S; Klugar M; Tanasiewicz M
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers.
    Otani J; Ohta R; Sano C
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.